e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
The new clinical spectrum of lung diseases: from bronchi to pleura
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis
K. Lai, D. Xu, J. Xie, W. Luo, N. Zhong (Guangzhou, China)
Source:
Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Session:
The new clinical spectrum of lung diseases: from bronchi to pleura
Session type:
Poster Discussion
Number:
483
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Lai, D. Xu, J. Xie, W. Luo, N. Zhong (Guangzhou, China). Different treatment courses with inhaled corticosteroids for eosinophilic bronchitis. Eur Respir J 2011; 38: Suppl. 55, 483
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Response to inhaled corticosteroids in patients with non-asthmatic eosinophilic bronchitis
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Efficacy of systemic corticosteroids in refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation
Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2010
Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004
An economic evaluation of adding inhaled corticosteroids to systemic corticosteroids for treating acute asthma exacerbations
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019
Exacerbations and inhaled corticosteroids in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
The effect of inhaled lidocaine-hydrofluoroalkane 134a in prednisone-dependent eosinophilic bronchitis
Source: Eur Respir J 2008; 32: 1119-1122
Year: 2008
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 260s
Year: 2001
Effects of montelukast on tapering inhaled corticosteroids in patients with asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002
Comparison of oral prednisolone and nebulized budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001
Comparison of inhaled corticosteroid combined with theophylline and double-dose inhaled corticosteroid in moderate-severe persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 127s
Year: 2004
Adding slow-released theophyllne to inhaled corticosteroids in the treatment of mild persistent asthma
Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma
Year: 2007
Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment
Source: Eur Respir J 2006; 27: 964-971
Year: 2006
Montelukast plus inhaled budesonide versus double dose inhaled budesonide in nonasthmatic eosinophilic bronchitis
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004
Airway autoimmunity and response to a 14-day course of oral corticosteroids in patients with severe eosinophilic asthma
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020
Risks of pneumonia in asthmatic patients taking inhaled corticosteroids
Source: Annual Congress 2010 - Management of airway disease
Year: 2010
Cough variant asthma treated with bronchodilators, without inhaled corticosteroids
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009
Oral corticosteroids in the treatment of exacerbation of severe asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept